Back
Ocular Therapeutix Vs. CytomX Therapeutics Industry Stock Comparison
Buy
69
OCUL
Ocular Therapeutix
Last Price:
6.18
Seasonality Move:
-2.15%
Sell
15
CTMX
CytomX Therapeutics
Last Price:
1.91
Seasonality Move:
-12.9%
Buy
69
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $6.17. The Score for OCUL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy, Sell or Hold?
- The current CytomX Therapeutics [CTMX] share price is $1.89. The Score for CTMX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- CTMX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $6.17
The current trend is relatively stagnant and OCUL is experiencing slight buying pressure.
CTMX Stock Price Chart
What is CytomX Therapeutics's stock price today?
-
The CytomX Therapeutics share price today is $1.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight selling pressure.
OCUL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 49.06 | Sell |
| Chaikin Money Flow: | 169488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.84 - 6.68) | Buy |
| Bollinger Bands (100): | (4.58 - 8.98) | Sell |
CTMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 42.5 | Sell |
| Chaikin Money Flow: | -1170152 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.28 - 3.58) | Sell |
| Bollinger Bands (100): | (1.3 - 2.72) | Sell |
OCUL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.96 | Buy |
| 20-day SMA: | 5.48 | Buy |
| 50-day SMA: | 7.4 | Sell |
| 200-day SMA: | 5.01 | Buy |
| 8-day EMA: | 6.01 | Buy |
| 20-day EMA: | 6.05 | Buy |
| 50-day EMA: | 6.62 | Sell |
| 200-day EMA: | 5.79 | Buy |
CTMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.24 | Sell |
| 20-day SMA: | 2.59 | Sell |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 1.69 | Buy |
| 8-day EMA: | 2.26 | Sell |
| 20-day EMA: | 2.46 | Sell |
| 50-day EMA: | 2.32 | Sell |
| 200-day EMA: | 1.9 | Sell |
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.19 per share, and an increase next year of $0.26 per share.
CytomX Therapeutics Earnings Growth & CTMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.41 per share.
Ocular Therapeutix Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytomX Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||